Moleculin Biotech, Inc. (MBRX) Description, Stock price, News & Info.

#ThinkSabio Latest News

MBRX – Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models – Data Presented at AACR 2026